VERONICA EBERHART: Open Payments
NPI 1073902094 · BRASELTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 60 payments from 14 companies in 2025. Trend: 2023 $1,424 · 2024 $1,692 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $280 |
| Novo Nordisk Inc | 4 | $247 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 20 | $214 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| BridgeBio Pharma, Inc. | 3 | $69 |
| Boston Scientific Corporation | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
Products named: VYNDAQEL, LifeVest, Wegovy, VERQUVO, Ozempic, Kerendia, Attruby, LEQVIO.
Industry payments across GA — which companies pay providers there.
